Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Apr 06, 2019 4:49am

126 Views

Post# 29591301

RE:Interesting Read

Bunge wrote: https://www.chicagotribune.com/suburbs/daily-southtown/community/chi-ugc-article-silver-cross-was-1st-to-offer-photodynamic-th-2019-04-03-story.html

Thanks for sharing. I haven't looked into it deeply yet but I'm guessing the only option here is fda approved photofrin or ala and whatever laser system which would clearly be inferior to Theralase ACT.

This basically means that Theralase would displace these treatments/companies/track records,,, like what silvercross has done and 95% of any other approved pdt treatment does, pretty much over night.

$$$

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments